Skip to main content

Table 4 Associations of adherence to 12 lifestyle recommendations at baseline with CESD-R-10 and GAD-7 scores at 1-year follow-up

From: The impact of 12 modifiable lifestyle behaviours on depressive and anxiety symptoms in middle adolescence: prospective analyses of the Canadian longitudinal COMPASS study

 

Univariate

Multivariable*

Model 1

Model 2

Total

Total

Total

Females

Males

β (95% CI)

β (95% CI)

β (95% CI)

β (95% CI)

β (95% CI)

Adherence to individual recommendations for:

Depressive symptoms

 Vegetables and fruit

-0.29 (-0.68, 0.10)

-0.40 (-0.71, -0.09)

-0.26 (-0.57, 0.06)

-0.17 (-0.59, 0.24)

-0.45 (-0.95, 0.06)

 Grain products

-0.35 (-0.71, 0.02)

-0.19 (-0.49, 0.10)

-0.06 (-0.36, 0.24)

-0.02 (-0.47, 0.44)

-0.11 (-0.51, 0.28)

 Milk and alternatives

-0.89 (-1.05, -0.73)

-0.09 (-0.22, 0.04)

-0.03 (-0.16, 0.10)

-0.03 (-0.23, 0.16)

-0.04 (-0.22, 0.13)

 Meat and alternatives

-0.30 (-0.45, -0.14)

-0.28 (-0.41, -0.16)

-0.24 (-0.37, -0.11)

-0.38 (-0.56, -0.19)

-0.10 (-0.28, 0.08)

 SSB

-0.76 (-0.93, -0.59)

-0.28 (-0.42, -0.15)

-0.20 (-0.34, -0.06)

-0.19 (-0.38, 0.00)

-0.22 (-0.42, -0.03)

 MVPA

-0.46 (-0.62, -0.31)

0.05 (-0.08, 0.18)

0.08 (-0.05, 0.21)

0.31 (0.12, 0.50)

-0.19 (-0.36, -0.01)

 Screen time

-1.79 (-2.14, -1.44)

-0.76 (-1.04, -0.48)

-0.65 (-0.93, -0.36)

-0.76 (-1.13, -0.39)

-0.41 (-0.86, 0.04)

 Sleep

-1.98 (-2.13, -1.83)

-0.49 (-0.62, -0.37)

-0.45 (-0.58, -0.33)

-0.53 (-0.71, -0.34)

-0.38 (-0.56, -0.20)

 No tobacco smoking

-1.89 (-2.20, -1.59)

-0.24 (-0.48, 0.01)

-0.03 (-0.31, 0.26)

0.02 (-0.40, 0.45)

-0.03 (-0.41, 0.35)

 No vaping

-1.02 (-1.23, -0.81)

-0.19 (-0.36, -0.02)

-0.04 (-0.24, 0.16)

0.10 (-0.18, 0.39)

-0.16 (-0.43, 0.11)

 No cannabis use

-1.81 (-2.03, -1.59)

-0.36 (-0.55, -0.18)

-0.29 (-0.51, -0.07)

-0.23 (-0.55, 0.09)

-0.37 (-0.68, -0.06)

 No binge drinking

-1.09 (-1.26, -0.91)

-0.12 (-0.27, 0.03)

0.06 (-0.12, 0.23)

0.06 (-0.18, 0.31)

0.06 (-0.19, 0.30)

Adherence to individual recommendations for:

Anxiety symptoms

 Vegetables and fruit

0.32 (-0.03, 0.68)

-0.07 (-0.35, 0.21)

0.01 (-0.27, 0.29)

0.00 (-0.36, 0.37)

-0.02 (-0.48, 0.44)

 Grain products

-0.07 (-0.41, 0.26)

0.02 (-0.24, 0.29)

0.07 (-0.20, 0.34)

-0.04 (-0.45, 0.36)

0.15 (-0.20, 0.50)

 Milk and alternatives

-0.71 (-0.85, -0.57)

0.04 (-0.07, 0.16)

0.08 (-0.04, 0.19)

0.09 (-0.09, 0.26)

0.06 (-0.10, 0.22)

 Meat and alternatives

0.09 (-0.05, 0.23)

-0.19 (-0.30, -0.08)

-0.19 (-0.30, -0.07)

-0.27 (-0.44, -0.11)

-0.08 (-0.25, 0.08)

 SSB

-0.66 (-0.81, -0.51)

-0.26 (-0.38, -0.14)

-0.19 (-0.31, -0.07)

-0.21 (-0.38, -0.04)

-0.19 (-0.37, -0.01)

 MVPA

-0.42 (-0.56, -0.27)

0.09 (-0.03, 0.20)

0.10 (-0.02, 0.21)

0.29 (0.13, 0.46)

-0.11 (-0.27, 0.05)

 Screen time

-1.14 (-1.46, -0.82)

-0.64 (-0.89, -0.39)

-0.55 (-0.80, -0.29)

-0.60 (-0.93, -0.27)

-0.46 (-0.86, -0.06)

 Sleep

-1.53 (-1.67, -1.39)

-0.40 (-0.51, -0.29)

-0.37 (-0.49, -0.26)

-0.32 (-0.49, -0.16)

-0.46 (-0.62, -0.30)

 No tobacco smoking

-1.36 (-1.63, -1.09)

-0.15 (-0.37, 0.07)

0.10 (-0.15, 0.35)

0.19 (-0.18, 0.56)

0.02 (-0.31, 0.36)

 No vaping

-0.82 (-1.01, -0.64)

-0.23 (-0.38, -0.08)

-0.13 (-0.31, 0.04)

-0.12 (-0.38, 0.13)

-0.08 (-0.32, 0.16)

 No cannabis use

-1.47 (-1.67, -1.26)

-0.34 (-0.50, -0.17)

-0.29 (-0.49, -0.10)

-0.15 (-0.44, 0.13)

-0.49 (-0.77, -0.22)

 No binge drinking

-0.98 (-1.14, -0.82)

-0.09 (-0.23, 0.04)

0.11 (-0.05, 0.26)

0.15 (-0.06, 0.37)

0.07 (-0.15, 0.28)

  1. β: unstandardized regression coefficient; 95% CI: 95% confidence interval; MVPA: moderate-to-vigorous physical activity; SSB: sugar-sweetened beverages
  2. *In linear mixed-effects models, Model 1 was adjusted for age, ethnicity, weight status, weight perception, weight loss attempts, school- area median household income, school area urban class, and mental health at baseline (CESD-R-10 and GAD-7 scores, as appropriate). Model 2 was adjusted for the covariates listed for Model 1 and mutually adjusted for all other lifestyle behaviours. Not meeting recommendations was the reference category in all analyses presented in Table 4. 95% CIs that do not include the null value are bolded